Similar Search Results

Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement

Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252

Persistent link: https://www.econbiz.de/10011317852

Productivity in pharmaceutical-biotechnology R&D : the role of experience and alliances

Danzon, Patricia Munch; Nicholson, Sean; Pereira, Nuno Sousa - In: Journal of health economics 24 (2005) 2, pp. 317-339

Persistent link: https://www.econbiz.de/10002638165

The impact of price regulation on the launch delay of new drugs : evidence from twenty-five major markets in the 1990s

Danzon, Patricia Munch; Wang, Yng-Yuh Richard; Wang, Liang - In: Health economics 14 (2005) 3, pp. 269-292

Persistent link: https://www.econbiz.de/10002709522

The impact of price regulation on the launch delay of new drugs : evidence from twenty-five major markets in the 1990s

Danzon, Patricia Munch; Wang, Yng-Yuh Richard; Wang, Liang - 2003

Persistent link: https://www.econbiz.de/10001785484

Price, financial quality, and capital flows in insurance markets

Cummins, John David - In: Journal of financial intermediation 6 (1997) 1, pp. 3-38

Persistent link: https://www.econbiz.de/10001217363

Productivity in pharmaceutical-biotechnology R&D : the role of experience and alliances

Danzon, Patricia Munch; Nicholson, Sean; Pereira, Nuno Sousa - 2003

Persistent link: https://www.econbiz.de/10001753253

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

Danzon, Patricia Munch - 2003

This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....

Persistent link: https://www.econbiz.de/10012468823